ALKS 5461 Placebo: Clinical Trials

1 trial of ALKS 5461 Placebo, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Completed 1

Follow ALKS 5461 Placebo: new trials by email Literature Review of ALKS 5461 Placebo trials Research Report on ALKS 5461 Placebo

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of ALKS 5461 for Treatment Refractory Major Depressive Disorder (MDD)
ALKS 5461, ALKS 5461 Placebo - Major Depressive Disorder
Phase 3CompletedAlkermes, Inc.2782017-06-122021-04-08

Conditions studied

Depressive Disorder, Major (1)

Sponsors

Alkermes, Inc. (1)

Countries

Australia (1)  ·  Puerto Rico (1)  ·  United States (1)

Top investigators

Sanjeev Pathak, MD (1)